Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's After-Market Session

Author: Benzinga Insights | February 09, 2024 05:31pm

Gainers

  • Singular Genomics Sys (NASDAQ:OMIC) shares moved upwards by 17.9% to $0.66 during Friday's after-market session. The market value of their outstanding shares is at $48.4 million.
  • Vaccinex (NASDAQ:VCNX) stock increased by 11.61% to $0.77. The company's market cap stands at $9.6 million.
  • Celularity (NASDAQ:CELU) shares moved upwards by 7.52% to $0.46. The market value of their outstanding shares is at $99.5 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) stock rose 6.87% to $0.62. The company's market cap stands at $1.0 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) stock moved upwards by 5.21% to $2.22. The company's market cap stands at $66.4 million.
  • Turnstone Biologics (NASDAQ:TSBX) shares rose 4.62% to $2.26. The market value of their outstanding shares is at $52.1 million.

Losers

  • Intelligent Bio Solutions (NASDAQ:INBS) stock declined by 15.8% to $5.7 during Friday's after-market session. The market value of their outstanding shares is at $4.1 million.
  • Perspective Therapeutics (AMEX:CATX) stock fell 8.9% to $0.82. The company's market cap stands at $405.5 million.
  • NanoString Technologies (NASDAQ:NSTG) stock decreased by 7.83% to $0.21. The market value of their outstanding shares is at $10.2 million.
  • Bone Biologics (NASDAQ:BBLG) shares declined by 6.36% to $3.83. The company's market cap stands at $2.0 million.
  • Actinium Pharma (AMEX:ATNM) stock decreased by 4.95% to $5.19. The market value of their outstanding shares is at $144.0 million.
  • Biolase (NASDAQ:BIOL) stock declined by 4.94% to $0.48. The company's market cap stands at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ATNM BBLG BIOL BTAI CATX CELU INBS NSTG OMIC TSBX VCNX ZVSA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist